| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.012 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.011 | 1 |